Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Laura C. Geben"'
Autor:
Stephen C Zambrzycki, Celine Caillet, Serena Vickers, Marcos Bouza, David V Donndelinger, Laura C Geben, Matthew C Bernier, Paul N Newton, Facundo M Fernández
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 9, p e0009360 (2021)
BackgroundPost-market surveillance is a key regulatory function to prevent substandard and falsified (SF) medicines from being consumed by patients. Field deployable technologies offer the potential for rapid objective screening for SF medicines.Meth
Externí odkaz:
https://doaj.org/article/1b4cae14dc04440d863eba3cc2483985
Autor:
Laura C. Geben, Asa A. Brockman, Mary Bronwen L. Chalkley, Serena R. Sweet, Julia E. Gallagher, Alexandra L. Scheuing, Richard B. Simerly, Kevin C. Ess, Jonathan M. Irish, Rebecca A. Ihrie
Publikováno v:
bioRxiv
A limiting factor in the regenerative capacity of the adult brain is the abundance and proliferative ability of neural stem cells (NSCs). Adult NSCs are derived from a subpopulation of embryonic NSCs that temporarily enter quiescence during mid-gesta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3198b90449be7eb2cf47c3dcc1efda3
https://europepmc.org/articles/PMC9948964/
https://europepmc.org/articles/PMC9948964/
Autor:
Stephen C, Zambrzycki, Celine, Caillet, Serena, Vickers, Marcos, Bouza, David V, Donndelinger, Laura C, Geben, Matthew C, Bernier, Paul N, Newton, Facundo M, Fernández
Publikováno v:
PLoS Neglected Tropical Diseases
Background Post-market surveillance is a key regulatory function to prevent substandard and falsified (SF) medicines from being consumed by patients. Field deployable technologies offer the potential for rapid objective screening for SF medicines. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c6ddb368829409246aaf25f658342c3
https://pubmed.ncbi.nlm.nih.gov/34591844
https://pubmed.ncbi.nlm.nih.gov/34591844
Autor:
Bret C. Mobley, Rob Naftel, Laura C. Geben, Adam J. Esbenshade, Asa A. Brockman, Devang Pastakia, Rebecca A. Ihrie
Publikováno v:
Pediatr Blood Cancer
One goal of precision medicine is to identify mutations within individual tumors to design targeted treatment approaches. This report details the use of genomic testing to select a targeted therapy regimen of erlotinib and rapamycin for a pediatric a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8bd732b42883e2af2f2a45559113fec
https://doi.org/10.1002/pbc.28750
https://doi.org/10.1002/pbc.28750
Autor:
Paul N. Newton, Celine Caillet, Facundo M. Fernández, Laura C. Geben, Stephen Zambrzycki, Serena Vickers, Marcos Bouza, Matthew C. Bernier, David V. Donndelinger
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 9, p e0009360 (2021)
Background Post-market surveillance is a key regulatory function to prevent substandard and falsified (SF) medicines from being consumed by patients. Field deployable technologies offer the potential for rapid objective screening for SF medicines. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a488798449d05ea0005cff489231e0
https://doi.org/10.1371/journal.pntd.0009360
https://doi.org/10.1371/journal.pntd.0009360